Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Pediatrics|June 24, 2025
RSV bronchiolitis: a disease only for those who do not receive prophylaxisA Villani, L Antilici, A M C Musolino, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2017
Respiratory viruses and influenza-like illness: a survey in the area of Rome, winter 2004-2005G Rezza, C Valdarchi, S Puzelli, et al.
Infection|June 16, 2011
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistanceC Sarrecchia, V Svicher, A Volpi, et al.
La Clinica Terapeutica|June 11, 1998
[Correlation between HIV-inhibiting drug activity in human macrophages and clinical outcome]S Aquaro, E Balestra, S Panti, et al.
Antiviral Research|October 1, 1994
9-(2-Phosphonylmethoxyethyl) adenine increases the survival of influenza virus-infected mice by an enhancement of the immune systemN Villani, R Caliò, E Balestra, et al.
Virology|October 12, 2007
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytesM Pollicita, D Schols, S Aquaro, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 30, 2006
Respiratory viruses and influenza-like illness: a survey in the area of Rome, winter 2004-2005G Rezza, C Valdarchi, S Puzelli, et al.
Antiviral Research|April 1, 1992
Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophagesC F Perno, R Yarchoan, J Balzarini, et al.
Nucleosides & Nucleotides|August 5, 1999
Synthesis and biological application of a new heterodinucleotide with both anti-HSV and anti-HIV activityP Franchetti, G Abu Sheikha, L Cappellacci, et al.
AIDS Patient Care and Stds|March 5, 2002
Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapineM Zaccarelli, A Barracchini, P De Longis, et al.
Pageof 14